Pharmaceutical Performance Powered by Gattefossé
Gattefossé is a leading innovator and supplier of lipidic excipients and lipid based technologies for oral, topical and rectal route drug delivery.
Gattefossé lipidic excipients have been developed to improve the performance of final dosage forms, in particular, for difficult to formulate actives. Gattefossé functional excipients are applied to improve API solubility, bioavailability and to modify drug release.
Lipidic formulations offer distinct advantages over other methods of improving drug / formulation performance including certain physicochemical modifications of API (prodrug development, nanomilling etc).
Gattefossé has been developing and supplying lipidic excipients for over a century. We have a global reputation as a leading supplier of speciality excipients. Our R&D and Applications Laboratories enable us to remain at the forefront of lipidic product and formulation expertise.
Product Regulatory Status
Gattefossé lipid excipients are derived from vegetable origin. Their quality and safety are well documented with safety studies and / or registrations with regulatory agencies worldwide. Gattefossé is a driving force for the development of new USP/NF and EP monographs. As such our products are supported with pharmacopoeia status including USP/NF, EP, and JPE/JP, as well as other internationally recognized criteria: FDA IIG, GRAS, FDA FCC etc.
Through our Applications Laboratory and Customer Services division we provide extensive support to our customers. We can provide 'proof of concept' formulations for novel formulations, including powders, granules, tablets, capsules, ointments, emulsions, microemulsions and suppositories. Our technical support not only covers excipient and formulation expertise but we also offer extensive regulatory advice about the use of our products in final dosage forms.
| Formulation Solutions:
Lipidic excipients for oral dosage forms :
Semi-solid and liquid bioavailability enhancers for tablets, capsules and sachets Solubility enhancers Liquid and semi-solid oily vehicles Excipients for sustained release Versatile lubricants Taste-masking agents
Drug Delivery Systems for oral dosage forms :
Self Emulsifying Lipidic Formulations for oral dosage forms (SEDDS/SMEDDS) Hot melt coating (Gattecoat®) and spray cooling
Lipidic excipients for topical dosage forms :
Emulsifying bases for creams & lotions Emollients and thickeners Excipients for microemulsions Solubilizers and oily vehicles
Excipients for rectal and vaginal dosage forms
Suppository and pessary bases
Gattefossé Registered Trademarks include:
CAPRYOL™, COMPRITOL® 888 ATO, GELOIL™ SC, GELUCIRE®, LABRAFAC™, LABRAFIL, LABRASOL®, LAUROGLYCOL™, MAISINE™, PECEOL™, PLUROL®, PRECIROL®, SUPPOCIRE®, TEFOSE®, and TRANSCUTOL®.
GMP & ISO Certification
Gattefossé manufacturing practices meet the strictest of quality and safety standards and our production site in St Priest, France is ISO9001 V2000 certified. Our facilities are regularly audited for GMP compliance and have been visited / approved by many multinational pharmaceutical companies.
Gattefossé has sales and distribution centers located in more than 40 countries across five continents.
36 chemin de Genas
BP 603 - F-69804
Saint-Priest Cedex - France
Tel. +33 4 72 22 98 00